Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Squaremind |
| Country | France |
| Start Date | Jul 01, 2022 |
| End Date | Dec 31, 2024 |
| Duration | 914 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 190119289 |
Swan is a breakthrough solution to the enduring problem of detecting skin cancer early.
For the first time, Swan enables *full-body* scanning at *dermoscopic* resolution and in less than *3* minutes to the benefit of *all* stakeholders: patients, physicians, hospitals and payers.The solution captures key data that dermatologists acutely need for early diagnosis and brings breakthrough AI triage assistance to flag concerning lesions.
Significant medical time is saved in the process and for patients, the impact is faster access to treatment when needed, fewer unnecessary biopsies and peace of mind.
The solution combines hardware and software and is at the crossroads of cutting-edge, patented technologies in real-time 3D human avatar generation, advanced robotic control, image processing and AI classification of lesions.
Our ambition is to make best-in-class skin cancer screening accessible to everyone, everywhere and finally help dermatology make a quantum leap forward.
Squaremind
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant